Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Cancer Research|January 10, 2002
Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitorChinthalapally V Rao, Cooma Indranie, Barbara Simi, et al.
The Prostate|September 27, 2008
Inflammatory processes of prostate tissue microenvironment drive rat prostate carcinogenesis: preventive effects of celecoxibNarayanan K Narayanan, Dominick Nargi, Lori Horton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2007
Pterostilbene, an active constituent of blueberries, suppresses aberrant crypt foci formation in the azoxymethane-induced colon carcinogenesis model in ratsNanjoo Suh, Shiby Paul, Xingpei Hao, et al.
Carcinogenesis|September 26, 2007
Green tea polyphenols inhibit colorectal aberrant crypt foci (ACF) formation and prevent oncogenic changes in dysplastic ACF in azoxymethane-treated F344 ratsHang Xiao, Xingpei Hao, Barbara Simi, et al.
Molecular Carcinogenesis|October 13, 2007
Chemoprevention of familial adenomatous polyposis in Apc(Min/+) mice by phenethyl isothiocyanate (PEITC)Tin Oo Khor, William Ka Lung Cheung, Auemduan Prawan, et al.
Molecular Cancer Therapeutics|February 27, 2004
Modulation of cyclooxygenase-2 activities by the combined action of celecoxib and decosahexaenoic acid: novel strategies for colon cancer prevention and treatmentMalisetty V Swamy, Indranie Cooma, Jagan M R Patlolla, et al.
Cancer Research|July 20, 2006
Chemoprevention of familial adenomatous polyposis by low doses of atorvastatin and celecoxib given individually and in combination to APCMin miceMalisetty V Swamy, Jagan M R Patlolla, Vernon E Steele, et al.
Cancer Research|December 21, 2006
Nrf2-deficient mice have an increased susceptibility to dextran sulfate sodium-induced colitisTin Oo Khor, Mou-Tuan Huang, Ki Han Kwon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2007
Exisulind in combination with celecoxib modulates epidermal growth factor receptor, cyclooxygenase-2, and cyclin D1 against prostate carcinogenesis: in vivo evidenceBhagavathi A Narayanan, Bandaru S Reddy, Maarten C Bosland, et al.
Carcinogenesis|January 20, 2004
Enhancement of development of azoxymethane-induced colonic premalignant lesions in C57BL/KsJ-db/db miceYoshinobu Hirose, Kazuya Hata, Toshiya Kuno, et al.
Pageof 5